Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | tolbutamide | 5505 | drug-path |
Long-term potentiation | R-HSA-9620244 | map04720 | tolbutamide | 5505 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | tolbutamide | 5505 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | dexverapamil | 65808 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | dexverapamil | 65808 | drug-path |
Thyroid cancer | R-HSA-9700206 | map05216 | dexverapamil | 65808 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | dexverapamil | 65808 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | dexverapamil | 65808 | drug-path |
Melanogenesis | R-HSA-5662702 | map04916 | verapamil | 2520 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | verapamil | 2520 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | verapamil | 2520 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | verapamil | 2520 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | verapamil | 2520 | drug-path |
Gap junction | R-HSA-190861 | map04540 | verapamil | 2520 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | verapamil | 2520 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | verapamil | 2520 | drug-path |
Long-term depression | R-HSA-9620244 | map04730 | verapamil | 2520 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | verapamil | 2520 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | verapamil | 2520 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | verapamil | 2520 | drug-path |